Consolidating the Digital Slide: How Agilent's $270M Proscia Acquisition Signals the End of Standalone Pathology AI
Dr. Dereck Mush, MD, MBA
Ibex Medical Analytics
Applies artificial intelligence to cancer diagnostics in digital pathology workflows.
What they do
Ibex Medical Analytics provides AI-powered software solutions for pathology laboratories. Its Galen platform analyzes tissue biopsies to assist pathologists in detecting cancer, grading tumor severity, and streamlining diagnostic workflows, thereby reducing errors and turnaround times.
The record
- Vertical
- Oncology
- Sub-segment
- AI-powered pathology diagnostics
- Product type
- Software as a medical device
- Stage
- Series C+
- Headquarters
- Tel Aviv, Israel
- Region
- Middle East & Africa
- Founded
- 2016
- Total funding
- $102M raised
Notable investors: 83North, aMoon Venture Capital, Siena Venture Capital, Octopus Ventures.
Also in Oncology
Related on The Signal
Dr. Dereck Mush, MD, MBA
Breaking the PMA Bottleneck: How FDA's Class II Reclassification Accelerates Precision Oncology
Dr. Dereck Mush, MD, MBA
Digital Pathology Finally Has FDA-Cleared AI. Why Hospital Adoption Is Still Spotty
Dr. Dereck Mush, MD, MBA
The Curative Adjuvant Checkpoint Pivot: How Genentech's ATOMIC Approval Redefines Early GI Oncology Economics and Reflex Testing Infrastructure
Dr. Dereck Mush, MD, MBA